Australia markets open in 12 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.72-0.20 (-0.51%)
At close: 04:00PM EDT
38.72 0.00 (0.00%)
After hours: 04:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.17B
Enterprise value 4.46B
Trailing P/E 24.63
Forward P/E 10.96
PEG ratio (5-yr expected) 0.91
Price/sales (ttm)2.08
Price/book (mrq)1.88
Enterprise value/revenue 2.89
Enterprise value/EBITDA 13.61

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-10.30%
S&P500 52-week change 317.14%
52-week high 360.69
52-week low 337.36
50-day moving average 342.77
200-day moving average 349.91

Share statistics

Avg vol (3-month) 3646.42k
Avg vol (10-day) 3752.01k
Shares outstanding 581.4M
Implied shares outstanding 681.4M
Float 870.26M
% held by insiders 113.15%
% held by institutions 192.34%
Shares short (30 Aug 2023) 42.57M
Short ratio (30 Aug 2023) 44.94
Short % of float (30 Aug 2023) 43.63%
Short % of shares outstanding (30 Aug 2023) 43.15%
Shares short (prior month 30 July 2023) 42.4M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Jan 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 June 2023


Profit margin 8.50%
Operating margin (ttm)16.44%

Management effectiveness

Return on assets (ttm)4.22%
Return on equity (ttm)7.85%

Income statement

Revenue (ttm)1.55B
Revenue per share (ttm)18.84
Quarterly revenue growth (yoy)-4.20%
Gross profit (ttm)982.03M
EBITDA 374.99M
Net income avi to common (ttm)131.27M
Diluted EPS (ttm)1.56
Quarterly earnings growth (yoy)-90.70%

Balance sheet

Total cash (mrq)329.39M
Total cash per share (mrq)4.05
Total debt (mrq)1.61B
Total debt/equity (mrq)95.36%
Current ratio (mrq)2.79
Book value per share (mrq)20.69

Cash flow statement

Operating cash flow (ttm)208.08M
Levered free cash flow (ttm)224.21M